ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

10,769Medicare Part D Prescriptions Filled, Including Refills

Rank: 90 out of 387

$561K Total Retail Price of All Prescriptions

Rank: 121 out of 387

422 Patients Receiving at Least One Drug in Part D
90%Patients 65 Years and Older
7% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Oklahoma
Lower avg

Schedule Two
Controlled Substances

6% of this provider’s 422 patients filled at least one prescription for a schedule two drug, compared to an average of 5%.

Schedule Three
Controlled Substances

12% of this provider’s 422 patients filled at least one prescription for a schedule three drug, compared to an average of 16%.

Risky Drugs to Seniors

2% of this provider’s 9,911 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

19% of this provider’s prescriptions were for brand-name drugs, compared to an average of 25%.

Prescription Price

$52 was the average price of a prescription from this provider, compared to $64 among peers.

Prescriptions per Patient

26 is the average number of prescriptions (including refills) per patient, compared to an average of 21.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Oklahoma
AMLODIPINE BESYLATE 455 441 1 6
LEVOTHYROXINE SODIUM 423 415 2 2
LISINOPRIL 418 370 3 3
FUROSEMIDE 335 320 4 7
SIMVASTATIN 329 304 5 5
GABAPENTIN 327 299 6 10
OMEPRAZOLE 301 281 7 4
PRAVASTATIN SODIUM 274 259 8 15
ATORVASTATIN CALCIUM 268 236 9 13
HYDROCODONE-ACETAMINOPHEN 233 179 S3 10 1
CITALOPRAM HBR 211 203 11 19
LOVASTATIN 211 204 11 36
TRAMADOL HCL 186 178 13 14
HYDROCHLOROTHIAZIDE 181 163 14 12
METFORMIN HCL 174 165 15 8
GLIMEPIRIDE 165 159 16 50
WARFARIN SODIUM 159 159 17 17
METFORMIN HCL ER 151 133 18 81
ZOLPIDEM TARTRATE 142 129 19 16
METOPROLOL TARTRATE 136 133 20 11
ATENOLOL 131 124 21 20
CARVEDILOL 131 119 21 21
BENAZEPRIL HCL 130 119 23 86
POTASSIUM CHLORIDE 129 121 24 9
LOSARTAN POTASSIUM 129 125 24 24
TAMSULOSIN HCL 118 117 26 32
METOPROLOL SUCCINATE 110 108 27 18
PREDNISONE 94 90 28 43
TRAZODONE HCL 92 84 29 37
FENOFIBRATE 88 78 30 106
FLUTICASONE PROPIONATE 88 75 30 29
CLOPIDOGREL 80 63 32 25
AZITHROMYCIN 80 74 32 49
POLYETHYLENE GLYCOL 3350 76 72 34 57
ALENDRONATE SODIUM 74 74 35 31
SERTRALINE HCL 71 67 36 23
ALLOPURINOL 70 66 37 28
MORPHINE SULFATE ER 70 65 S2 37 79
DONEPEZIL HCL 69 69 39 27
CELEBREX 66 58 40 72
ESTRADIOL 64 64 R 41 105
LISINOPRIL-HYDROCHLOROTHIAZIDE 58 58 42 30
RAMIPRIL 56 56 43 119
VENLAFAXINE HCL ER 56 49 43 97
PLAVIX 55 49 45 39
ADVAIR DISKUS 52 45 46 41
PROAIR HFA 52 38 46 47
NAMENDA 50 50 48 35
DIGOXIN 50 50 48 40
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 7, 2014.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.